MVP
MEDICALDEV FPO [MVP]
Healthcare · ASX Small Cap
$0.5200 +4.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-03-09
Get alerts when MVP triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD just crossed bullish — momentum is shifting to the upside
- Trading above both moving averages — the trend is your friend here
- On a tear — up 13.0% over the last 5 days
- Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Trading above the 200-day average — the long-term trend is on your side
- Cash positive / operating cashflow positive
- Low P/S ratio (1.4x)
- Moderate revenue growth (+10%)
- Piotroski F-Score strong (8/9, low-confidence approx)
- EPS estimates revised upward (+10pts)
- Small-cap ($20-100M)
- CANSLIM A: Turned profitable
- CANSLIM I: Institutional ownership (24%)
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (4.95%/day)
- RBA hiking (-3pts)
- Calendar: Clinical Trial in 6d (+5pts)
Risk Signals
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 21% over the past year
Expected next for MVP
Window: 1 Jul to 31 Dec
From a company announcement on 18 Feb 2026
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE MVP Announces FY26 Full Year Results
NONE FY26 Full Year Results
NONE Change in substantial holding
LOW FY26 Full year Results Investor Presentation
Recent ASX Announcements
| 2026-08-19 | MVP Announces FY26 Full Year Results PRICE SENSITIVE |
| 2026-08-19 | FY26 Full year Results Investor Presentation PRICE SENSITIVE |
| 2026-08-19 | FY26 Full Year Results PRICE SENSITIVE |
| 2026-08-17 | Change in substantial holding |
| 2026-08-12 | FY26 Full Year Results Announcement Details |
Key Metrics
$58.0M
Market Cap
246K
Avg Volume
1.0x
Vol Ratio
$0.36 — $0.77
52-Week Range
N/A
Short Interest
N/A
Cash Runway
1.1%
ROE
1.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | neutral | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 68% |
| L | Leader vs Laggard | pass | RS: 23 |
| I | Institutional Sponsorship | pass | Inst: 24% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Signal History
Performance of past signals for this ticker (tracked since Dec 2025)
1
Past Signals
+3.3%
Avg 5d Return
+0.0%
Best Return
+13.0%
Avg Peak Gain
Track MVP and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required